UTHealth in Houston and Athersys Announce Commencement of Patient Enrollment in a Phase 2 Trial Evaluating MultiStem® Cell Therapy in Trauma
DMN Newswire!,
Initiation of innovative clinical trial focused on reducing complications and enhancing patient recovery following trauma at…